Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020.
Katinka AlbrechtAnja StrangfeldUrsula MarschallJohanna CallhoffPublished in: RMD open (2023)
RA-ILD is rare and mainly affects elderly persons. No trend in incidence was observed but treatment strategies have enlarged. Specialist care is necessary to provide disease-specific therapies. The continuing high analgesic and opioid demand shows unmet needs in these patients.
Keyphrases
- interstitial lung disease
- rheumatoid arthritis
- systemic sclerosis
- risk factors
- end stage renal disease
- idiopathic pulmonary fibrosis
- palliative care
- ejection fraction
- disease activity
- healthcare
- pain management
- chronic kidney disease
- newly diagnosed
- prognostic factors
- chronic pain
- peritoneal dialysis
- emergency department
- quality improvement
- ankylosing spondylitis
- spinal cord injury
- neuropathic pain
- systemic lupus erythematosus
- patient reported outcomes
- patient reported
- health insurance
- medical education